A new approach to fighting skin cancer has shown promise. Melanoma, a particularly aggressive form, may be prevented from recurring with the help of a tailored vaccine. This vaccine, known as Intismeran, is designed for individuals who have already had melanoma.

It is being developed by two companies, who report that it can be paired with another treatment for enhanced effectiveness. The vaccine uses a specific technology to target unique mutations within tumors.

Results from trials suggest that this vaccine may stop the disease from progressing, although further details are available from the source for those seeking more information.